Wild-Type p53: Tumors Can't Stand It

@article{Kastan2007WildTypePT,
  title={Wild-Type p53: Tumors Can't Stand It},
  author={Michael B. Kastan},
  journal={Cell},
  year={2007},
  volume={128},
  pages={837-840}
}
Most malignant tumors disrupt the p53 signaling pathway in order to grow and survive. Although many genes in addition to p53 are mutated in tumors, recent studies by Ventura et al. (2007) and Xue et al. (2007) suggest that restoring p53 function alone is sufficient to cause regression of several different tumor types in mice and thus might represent a potent therapeutic strategy to treat certain human cancers. Martins et al. (2006) also demonstrate that restoration of p53 activity results in… CONTINUE READING

1 Figure or Table